| Full text | |
| Author(s): Show less - |
Rius, Flavia E.
;
Papaiz, Debora D.
;
Azevedo, Hatylas F. Z.
;
Ayub, Ana Luisa P.
;
Pessoa, Diogo O.
;
Oliveira, Tiago F.
;
Loureiro, Ana Paula M.
;
Andrade, Fernando
;
Fujita, Andre
;
Reis, Eduardo M.
;
Mason, Christopher E.
;
Jasiulionis, Miriam G.
Total Authors: 12
|
| Document type: | Journal article |
| Source: | CLINICAL EPIGENETICS; v. 14, n. 1, p. 20-pg., 2022-12-01. |
| Abstract | |
The epigenetic changes associated with melanoma progression to advanced and metastatic stages are still poorly understood. To shed light on the CpG methylation dynamics during melanoma development, we analyzed the methylome profiles of a four-stage cell line model of melanoma progression: non-tumorigenic melanocytes (melan-a), premalignant melanocytes (4C), non-metastatic melanoma cells (4C11-), and metastatic melanoma cells (4C11+). We identified 540 hypo- and 37 hypermethylated gene promoters that together characterized a malignancy signature, and 646 hypo- and 520 hypermethylated promoters that distinguished a metastasis signature. Differentially methylated genes from these signatures were correlated with overall survival using TCGA-SKCM methylation data. Moreover, multivariate Cox analyses with LASSO regularization identified panels of 33 and 31 CpGs, respectively, from the malignancy and metastasis signatures that predicted poor survival. We found a concordant relationship between DNA methylation and transcriptional levels for genes from the malignancy (Pyroxd2 and Ptgfrn) and metastasis (Arnt2, Igfbp4 and Ptprf) signatures, which were both also correlated with melanoma prognosis. Altogether, this study reveals novel CpGs methylation markers associated with malignancy and metastasis that collectively could improve the survival prediction of melanoma patients. (AU) | |
| FAPESP's process: | 19/23480-4 - Novel strategies for eliminating residual tumor cells using epigenetic therapy |
| Grantee: | Miriam Galvonas Jasiulionis |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 18/20775-0 - Non-coding RNAs involved with melanoma genesis and progression |
| Grantee: | Miriam Galvonas Jasiulionis |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 14/13663-0 - Integrating gene and microRNA expression, methylome and hidroxymethylome data from different phases of melanoma progression. |
| Grantee: | Miriam Galvonas Jasiulionis |
| Support Opportunities: | Regular Research Grants |